Correlates of protective immunity to Mycobacterium tuberculosis in humans.
about
Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generationDynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals.Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85AA longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses.Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cellsBCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model.Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosisInfectious diseases epidemiology.A single dose of vitamin D enhances immunity to mycobacteria.Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig modelEvidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaquesReduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosisCD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.Attenuated Mycobacterium marinum protects zebrafish against mycobacteriosis.Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS)Clinical applications of attenuated MVA poxvirus strain.Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCGImmune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients.Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres.Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG.SOCS1 gene expression is increased in severe pulmonary tuberculosis.Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies
P2860
Q28362814-9E7183E7-D91C-43A7-BD09-828A1D4ADC30Q33265416-9BBE5EC0-1EDC-4B57-8F3D-8EADB70FE09CQ33378483-5C9CCC65-EB47-4185-8F1E-58530CEAE3A5Q33408006-F4D60533-7A53-4874-B751-52A246653327Q33468451-05E5225F-87BF-439F-8D7E-7D267D091D5EQ33761119-AC0BFC05-A508-4FAD-A3C2-86BE22FE985FQ33946746-25ED56A8-17A9-4F4D-889A-DB8D3C68BF53Q34097601-4591C193-B628-48C0-BF0B-A6CD0FEBC9F2Q34139968-DE2CFCC8-7524-45FE-BE9B-1F1B365872F0Q34203521-94BF732B-AC0D-4785-9FBD-EB52B378C90CQ34251506-52B36725-2B42-4FD1-AEAC-ABA0347AD26AQ34361636-806FE0B8-7E75-43A5-B9FB-A98CC669BDE7Q34492775-A45FF79F-AE9A-4795-A86F-889CE2A66A80Q34494234-8F306A30-A72C-4FA5-ADCD-A9827FE46716Q34623455-E372D236-8CCF-4C39-86A5-36EC99D0D937Q34655555-E2D4F016-36AD-40D5-8D5F-8F66B78049B4Q34854931-B3BDC30B-D9D4-4F46-9504-DB37395B5F4BQ35088532-09A4E7CC-BBDE-415A-9BAD-2CEB3EA73F57Q36362277-3E0CB6B5-0FD1-4030-8BC2-53A1FA3EF5FEQ36403153-103E3BD3-C896-4912-AC77-E23E919C8D34Q37633244-C1F6FCA3-F6B7-4102-AC9F-A53B244F9277Q37714064-D22187BF-AC84-4C8E-9A8F-96BAD1932A2CQ38156198-F7784FFB-7A4C-4A2E-ABEC-26DCE4F3EDD7Q39607060-A4A550F3-281F-4257-BBA3-8A5C63299265Q40004825-13C3A47C-4F52-4786-BD8A-AF771C6DDE77Q46441246-0C9286EB-240C-4B49-A8BC-B6453D6DD59AQ47567586-9BF87E20-A078-4F29-999A-B1BF37A160FFQ47659867-FAAABA57-8B50-40F6-BF96-64BB28D98FA8Q56986364-9E9C5065-3987-436A-8019-460B2DECBC35
P2860
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
@ast
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
@en
type
label
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
@ast
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
@en
prefLabel
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
@ast
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
@en
P2860
P356
P1476
Correlates of protective immunity to Mycobacterium tuberculosis in humans.
@en
P2093
C C Whalen
C S Hirsch
P2860
P304
P356
10.1086/313874
P407
P478
30 Suppl 3
P577
2000-06-01T00:00:00Z